Sunday, September 29, 2024
HomeTagsProdrug ASC61

Prodrug ASC61

Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1

Ascletis Pharma Inc. announces the completion of first patient dosing in the U.S. Phase I clinical trial of ASC61, an oral PD-L1 small molecule...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics